T-cell-depleted hematopoietic SCT from unrelated donors for the treatment of congenital amegakaryocytic thrombocytopenia

10/10 TBI: 125 cGy TID 9/10 (A Mel: 60 mg/[m.sup.2]/d x

Saved in:
Bibliographic Details
Published inBone marrow transplantation (Basingstoke) Vol. 47; no. 5; pp. 744 - 746
Main Authors TAREK, N, KERNAN, N. A, PROCKOP, S. E, SCARADAVOU, A, SMALL, T. N, O'REILLY, R. J, BOULAD, F
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing Group 01.05.2012
Subjects
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Bone marrow
Bone marrow, stem cells transplantation. Graft versus host reaction
Care and treatment
Genetic aspects
Hematopoietic Stem Cell Transplantation - methods
Hematopoietic stem cells
Humans
Lymphocytes T
Medical sciences
Plant Lectins - therapeutic use
Soybean Proteins - therapeutic use
Stem cell transplantation
T-Lymphocytes - drug effects
T-Lymphocytes - immunology
Thrombocytopenia
Thrombocytopenia - therapy
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Transplantation
Unrelated Donors
United States
Depletion
Treatment
Congenital
Hematology
Unrelated donor
T-Lymphocyte
Homograft
Amegakaryocytic thrombocytopenia
Hematopoietic stem cell transplantation
Online AccessGet full text

Cover

More Information
Summary:10/10 TBI: 125 cGy TID 9/10 (A Mel: 60 mg/[m.sup.2]/d x
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0268-3369
1476-5365
DOI:10.1038/bmt.2011.142